Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy

Figure 5 The association between gamma-glutamyl transpeptidase-to-platelet ratio and death/recurrence risk and Kaplan-Meier stratified analysis between gamma-glutamyl transpeptidase-to-platelet ratio levels and prognosis in the solitary hepatitis B virus-related hepatocellular carcinoma cohort. A: The restricted cubic spline curves of gamma-glutamyl transpeptidase-to-platelet ratio levels. The risk was adjusted by age, cirrhosis, hepatitis B virus-DNA, tumor size, microvascular imaging, and infiltrative growth; B: Kaplan-Meier survival curves of overall survival (OS) and recurrence-free survival (RFS) in patients with solitary hepatocellular carcinoma (HCC) before propensity score matching (PSM); C: Triangle plot and absolute standardized differences adjustment of three groups; D: Kaplan-Meier survival curves of OS and RFS in patients with solitary HCC after PSM. OS: Overall survival; PSM: Propensity score matching; GPR: Gamma-glutamyl transpeptidase-to-platelet ratio; MVI: Microvascular imaging; HBV: Hepatitis B virus; BCLC: Barcelona Clinic Liver Cancer; BMI: Body mass index; HR: Hazard ratio; AFP: Alpha-fetoprotein.